| 000 | 00960nac a2200253 a 4500 | ||
|---|---|---|---|
| 003 | BD-DhGUBL | ||
| 005 | 20260511044502.0 | ||
| 008 | 260511s2011 njua 001 0 eng d | ||
| 020 | _a9780470184745 | ||
| 020 | _a9781118015377 | ||
| 040 |
_aBD-DhGUBL _cBD-DhGUBL _dBD-DhGUBL |
||
| 245 | 0 | 0 |
_aHIV-1 integrase : _bmechanism and inhibitor design / _cedited by Nouri Neamati. |
| 260 |
_aHoboken, New Jersey : _bJohn Wiley & Sons, _c c 2011. |
||
| 300 |
_axiii, 566 p. : _bill. ; |
||
| 490 | 1 | _aWiley series in drug discovery and development | |
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aHIV (Viruses) _xEnzymes. |
|
| 650 | 0 |
_aHIV (Viruses) _xEnzymes _xInhibitors. |
|
| 650 | 0 | _aAntiviral agents. | |
| 700 | 1 | _aNeamati, Nouri. | |
| 830 | 0 | _aWiley series in drug discovery and development | |
| 856 |
_uhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/9781118015377?download=true _yClick here to download |
||
| 942 |
_2ddc _cEBK |
||
| 999 |
_c6090 _d6090 |
||